CORRECTION article
Front. Pharmacol., 20 July 2020
Sec. Pharmacology of Anti-Cancer Drugs
Volume 11 - 2020 | https://doi.org/10.3389/fphar.2020.01107
RETRACTED: Corrigendum: AFAP1-AS1 Promotes Epithelial-Mesenchymal Transition and Tumorigenesis Through Wnt/β-Catenin Signaling Pathway in Triple-Negative Breast Cancer
A retraction of this article was approved in:
Retraction: Corrigendum: AFAP1-AS1 promotes epithelial-mesenchymal transition and tumorigenesis through Wnt/β-Catenin signaling pathway in triple-negative breast cancer
- Read retraction
- 1Department of Breast Oncology, Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, China
- 2Department of Neurology, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, China
Citation: Zhang K, Liu P, Tang H, Xie X, Kong Y, Song C, Qiu X and Xiao X (2020) Corrigendum: AFAP1-AS1 Promotes Epithelial-Mesenchymal Transition and Tumorigenesis Through Wnt/β-Catenin Signaling Pathway in Triple-Negative Breast Cancer. Front. Pharmacol. 11:1107. doi: 10.3389/fphar.2020.01107
Received: 02 February 2020; Accepted: 07 July 2020;
Published: 20 July 2020; Retracted: 16 January 2026.
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.